Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022 at 18:58 PM EDT
Gritstone bio (NASDAQ: GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.